PARP inhibitors and chemoradiation for rectal cancer
Lancet Gastroenterol Hepatol
.
2017 Jun;2(6):389-390.
doi: 10.1016/S2468-1253(17)30051-1.
Epub 2017 Mar 27.
Authors
Rob Glynne-Jones
1
,
Marcia Hall
2
Affiliations
1
Mount Vernon Centre for Cancer Treatment, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK. Electronic address: rob.glynnejones@nhs.net.
2
Mount Vernon Centre for Cancer Treatment, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK.
PMID:
28497749
DOI:
10.1016/S2468-1253(17)30051-1
No abstract available
Publication types
Comment
MeSH terms
Chemoradiotherapy
Humans
Poly(ADP-ribose) Polymerase Inhibitors*
Rectal Neoplasms*
Substances
Poly(ADP-ribose) Polymerase Inhibitors